Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach

A Systematic Comparison of Cockcroft-Gault and Modification of Diet in Renal Disease Equations for Classification of Kidney Dysfunction and Dosage Adjustment

(2012) Eun Jung Park et al.   ANNALS OF PHARMACOTHERAPY

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

(2012) R. Cantón et al.   CLINICAL MICROBIOLOGY AND INFECTION

Carbapenem antibiotics for serious infections

(2012) P. M. Hawkey et al.   BMJ-British Medical Journal

TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient

(2011) Federico Pea et al.   ANNALS OF PHARMACOTHERAPY

Therapeutic drug monitoring of antimicrobials

(2011) Jason A. Roberts et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

(2011) G.L. Daikos et al.   CLINICAL MICROBIOLOGY AND INFECTION

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach

(2011) J.W. Mouton et al.   CLINICAL MICROBIOLOGY AND INFECTION

Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay

(2011) Spyros Pournaras et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum  -lactamase production in clinical Enterobacteriaceae isolates

(2011) S. Polsfuss et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Implications of augmented renal clearance in critically ill patients

(2011) Andrew A. Udy et al.   Nature Reviews Nephrology

Use of Meropenem by Continuous Infusion to Treat a Patient with a Blakpc-2-Positive Klebsiella pneumoniae Blood Stream Infection

(2011) Vanessa P. Ho et al.   Surgical Infections

A Novel Approach to Pharmacodynamic Assessment of Antimicrobial Agents: New Insights to Dosing Regimen Design

(2011) Vincent H. Tam et al.   PLoS Computational Biology

Comparing Outcomes of Meropenem Administration Strategies Based on Pharmacokinetic and Pharmacodynamic Principles: A Qualitative Systematic Review

(2010) Jerrold Perrott et al.   ANNALS OF PHARMACOTHERAPY

In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase- Producing Klebsiella pneumoniae

(2010) C. C. Bulik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae

(2010) Johann D.D. Pitout   DRUGS

Stability of doripenem, imipenem and meropenem at elevated room temperatures

(2010) Rebecca A. Keel et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Stability of meropenem and doripenem solutions for administration by continuous infusion

(2010) K. Berthoin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy of carbapenems against a metallo- -lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model

(2010) M. Souli et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against Klebsiella pneumoniae Producing the KPC Carbapenemase versus That against Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model

(2009) C. C. Bulik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Resistance among and Therapeutic Options against Gram‐Negative Pathogens

(2009) James J. Rahal   CLINICAL INFECTIOUS DISEASES

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

(2009) Jason A. Roberts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Use of Carbapenems in the Treatment of Serious Infections

(2009) Robert P. Baughman   JOURNAL OF INTENSIVE CARE MEDICINE

Pharmacokinetic and Pharmacodynamic Properties of Meropenem

(2008) David P. Nicolau   CLINICAL INFECTIOUS DISEASES

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy

(2008) Julia Langgartner et al.   INTENSIVE CARE MEDICINE

Experience with extended-infusion meropenem in the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii

(2008) Donghao Wang   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS